Adverse reactions after intravascular iodinated contrast media administration and their management Position paper of European Society of Vascular Medicine

Mária Rašiová; Oliver Schlager; Christian Heiss; Marianne Brodmann; Dan Mircea Olinic; Vinko Boc; Giacomo Buso; Jill Belch; Lucia Mazzolai; Juraj Madaric

doi:10.1024/0301-1526/a001122

Adverse reactions after intravascular iodinated contrast media administration and their management Position paper of European Society of Vascular Medicine

Mária Rašiová
, Oliver Schlager
, Christian Heiss
, Marianne Brodmann
, Dan Mircea Olinic
, Vinko Boc
, Giacomo Buso
, Jill Belch
, Lucia Mazzolai
, Juraj Madaric (Lead / Corresponding author)

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

281 Downloads (Pure)

Abstract

Endovascular interventions and diagnostic examinations using iodinated contrast media (ICM) are standard of care in current vascular medicine. Although ICM use is generally considered safe, it may be associated with adverse reactions, vary from minor disturbances to rare, but severe life-threatening complications. This position paper of European Society of Vascular Medicine integrates current knowledge and summarizes the key information related to the use of intravascular ICM, serving as recommendation on prevention and management of acute, late, and very late adverse reactions. It should help the health professionals in all fields of vascular medicine to make decisions in daily practice for safe use of contrast media.

Original language	English
Pages (from-to)	193-203
Number of pages	11
Journal	Vasa - European Journal of Vascular Medicine
Volume	53
Issue number	3
Early online date	23 Apr 2024
DOIs	https://doi.org/10.1024/0301-1526/a001122
Publication status	Published - May 2024

Keywords

chemotoxic reaction
contrast-associated acute kidney injury
hypersensitivity
Iodinated contrast media

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1024/0301-1526/a001122Licence: CC BY

Final Published VersionFinal published version, 740 KBLicence: CC BY

Cite this

Rašiová, M., Schlager, O., Heiss, C., Brodmann, M., Olinic, D. M., Boc, V., Buso, G., Belch, J., Mazzolai, L., & Madaric, J. (2024). Adverse reactions after intravascular iodinated contrast media administration and their management Position paper of European Society of Vascular Medicine. Vasa - European Journal of Vascular Medicine, 53(3), 193-203. https://doi.org/10.1024/0301-1526/a001122

@article{afebcbcd765e4e52beeea26f1432a80d,

title = "Adverse reactions after intravascular iodinated contrast media administration and their management Position paper of European Society of Vascular Medicine",

abstract = "Endovascular interventions and diagnostic examinations using iodinated contrast media (ICM) are standard of care in current vascular medicine. Although ICM use is generally considered safe, it may be associated with adverse reactions, vary from minor disturbances to rare, but severe life-threatening complications. This position paper of European Society of Vascular Medicine integrates current knowledge and summarizes the key information related to the use of intravascular ICM, serving as recommendation on prevention and management of acute, late, and very late adverse reactions. It should help the health professionals in all fields of vascular medicine to make decisions in daily practice for safe use of contrast media.",

keywords = "chemotoxic reaction, contrast-associated acute kidney injury, hypersensitivity, Iodinated contrast media",

author = "M{\'a}ria Ra{\v s}iov{\'a} and Oliver Schlager and Christian Heiss and Marianne Brodmann and Olinic, \{Dan Mircea\} and Vinko Boc and Giacomo Buso and Jill Belch and Lucia Mazzolai and Juraj Madaric",

note = "Publisher Copyright: {\textcopyright} 2024 The Author(s)",

year = "2024",

month = may,

doi = "10.1024/0301-1526/a001122",

language = "English",

volume = "53",

pages = "193--203",

journal = "Vasa - European Journal of Vascular Medicine",

issn = "0301-1526",

publisher = "Hogrefe AG",

number = "3",

}

Rašiová, M, Schlager, O, Heiss, C, Brodmann, M, Olinic, DM, Boc, V, Buso, G, Belch, J, Mazzolai, L & Madaric, J 2024, 'Adverse reactions after intravascular iodinated contrast media administration and their management Position paper of European Society of Vascular Medicine', Vasa - European Journal of Vascular Medicine, vol. 53, no. 3, pp. 193-203. https://doi.org/10.1024/0301-1526/a001122

Adverse reactions after intravascular iodinated contrast media administration and their management Position paper of European Society of Vascular Medicine. / Rašiová, Mária; Schlager, Oliver; Heiss, Christian et al.
In: Vasa - European Journal of Vascular Medicine, Vol. 53, No. 3, 05.2024, p. 193-203.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Adverse reactions after intravascular iodinated contrast media administration and their management Position paper of European Society of Vascular Medicine

AU - Rašiová, Mária

AU - Schlager, Oliver

AU - Heiss, Christian

AU - Brodmann, Marianne

AU - Olinic, Dan Mircea

AU - Boc, Vinko

AU - Buso, Giacomo

AU - Belch, Jill

AU - Mazzolai, Lucia

AU - Madaric, Juraj

PY - 2024/5

Y1 - 2024/5

N2 - Endovascular interventions and diagnostic examinations using iodinated contrast media (ICM) are standard of care in current vascular medicine. Although ICM use is generally considered safe, it may be associated with adverse reactions, vary from minor disturbances to rare, but severe life-threatening complications. This position paper of European Society of Vascular Medicine integrates current knowledge and summarizes the key information related to the use of intravascular ICM, serving as recommendation on prevention and management of acute, late, and very late adverse reactions. It should help the health professionals in all fields of vascular medicine to make decisions in daily practice for safe use of contrast media.

AB - Endovascular interventions and diagnostic examinations using iodinated contrast media (ICM) are standard of care in current vascular medicine. Although ICM use is generally considered safe, it may be associated with adverse reactions, vary from minor disturbances to rare, but severe life-threatening complications. This position paper of European Society of Vascular Medicine integrates current knowledge and summarizes the key information related to the use of intravascular ICM, serving as recommendation on prevention and management of acute, late, and very late adverse reactions. It should help the health professionals in all fields of vascular medicine to make decisions in daily practice for safe use of contrast media.

KW - chemotoxic reaction

KW - contrast-associated acute kidney injury

KW - hypersensitivity

KW - Iodinated contrast media

U2 - 10.1024/0301-1526/a001122

DO - 10.1024/0301-1526/a001122

M3 - Article

C2 - 38651340

AN - SCOPUS:85191477092

SN - 0301-1526

VL - 53

SP - 193

EP - 203

JO - Vasa - European Journal of Vascular Medicine

JF - Vasa - European Journal of Vascular Medicine

IS - 3

ER -

Adverse reactions after intravascular iodinated contrast media administration and their management Position paper of European Society of Vascular Medicine

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Fingerprint

Cite this